Related references
Note: Only part of the references are listed.FTY720 Attenuates 6-OHDA-Associated Dopaminergic Degeneration in Cellular and Mouse Parkinsonian Models
Manru Ren et al.
NEUROCHEMICAL RESEARCH (2017)
Apolipoprotein E4 Suppresses Neuronal-Specific Gene Expression in Maturing Neuronal Progenitor Cells Exposed to HIV
Rebeca Geffin et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2017)
Sphingosine-1-phosphate receptor therapies: Advances in clinical trials for CNS-related diseases
Sinead O'Sullivan et al.
NEUROPHARMACOLOGY (2017)
Effect of Fingolimod on Brain Volume Loss in Patients with Multiple Sclerosis
Nicola De Stefano et al.
CNS DRUGS (2017)
Traumatic Brain Injury-Induced Neuronal Apoptosis is Reduced Through Modulation of PI3K and Autophagy Pathways in Mouse by FTY720
Li Zhang et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2016)
The multiple sclerosis drug fingolimod (FTY720) stimulates neuronal gene expression, axonal growth and regeneration
Sofia Anastasiadou et al.
EXPERIMENTAL NEUROLOGY (2016)
Oligodendrogliopathy in Multiple Sclerosis: Low Glycolytic Metabolic Rate Promotes Oligodendrocyte Survival
Malena B. Rone et al.
JOURNAL OF NEUROSCIENCE (2016)
Fingolimod induces neuroprotective factors in human astrocytes
Franziska S. Hoffmann et al.
JOURNAL OF NEUROINFLAMMATION (2015)
FTY720 attenuates excitotoxicity and neuroinflammation
Raffaela Cipriani et al.
JOURNAL OF NEUROINFLAMMATION (2015)
Sphingosine-l-Phosphate: Boon and Bane for the Brain
Gerhild van Echten-Deckert et al.
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY (2014)
Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial
Peter A. Calabresi et al.
LANCET NEUROLOGY (2014)
HIV and Aging: Effects on the Central Nervous System
Silvia Canizares et al.
SEMINARS IN NEUROLOGY (2014)
Neurorestorative effect of FTY720 in a rat model of Alzheimer's disease: Comparison with Memantine
Fatemeh Hemmati et al.
BEHAVIOURAL BRAIN RESEARCH (2013)
Derivation of sensory neurons and neural crest stem cells from human neural progenitor hNP1
Xiufang Guo et al.
BIOMATERIALS (2013)
FTY720 (Fingolimod) Attenuates Beta-amyloid Peptide (Aβ42)-Induced Impairment of Spatial Learning and Memory in Rats
Masoumeh Asle-Rousta et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2013)
Apolipoprotein E-Dependent Differences in Innate Immune Responses of Maturing Human Neuroepithelial Progenitor Cells Exposed to HIV-1
Rebeca Geffin et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
Fingolimod: Direct CNS effects of sphingosine 1-phosphate (S1P) receptor modulation and implications in multiple sclerosis therapy
Aran Groves et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2013)
TGF-beta superfamily member activin A acts with BDNF and erythropoietin to improve survival of spiral ganglion neurons in vitro
Odett Kaiser et al.
NEUROPHARMACOLOGY (2013)
Fingolimod Phosphate Attenuates Oligomeric Amyloid β-Induced Neurotoxicity via Increased Brain-Derived Neurotrophic Factor Expression in Neurons
Yukiko Doi et al.
PLOS ONE (2013)
FTY720/Fingolimod, a Sphingosine Analogue, Reduces Amyloid-β Production in Neurons
Nobumasa Takasugi et al.
PLOS ONE (2013)
Fingolimod protects cultured cortical neurons against excitotoxic death
Luisa Di Menna et al.
PHARMACOLOGICAL RESEARCH (2013)
Cerebral β-amyloid deposition predicts HIV-associated neurocognitive disorders in APOE ε4 carriers
Virawudh Soontornniyomkij et al.
AIDS (2012)
Clinical Pharmacokinetics of Fingolimod
Olivier J. David et al.
CLINICAL PHARMACOKINETICS (2012)
The role and mechanism of action of activin A in neurite outgrowth of chicken embryonic dorsal root ganglia
Lin Fang et al.
JOURNAL OF CELL SCIENCE (2012)
Depressed neurofilament expression associates with apolipoprotein E3/E4 genotype in maturing human fetal neurons exposed to HIV-1
Ricardo Martinez et al.
JOURNAL OF NEUROVIROLOGY (2012)
Cognition, glucose metabolism and amyloid burden in Alzheimer's disease
Ansgar J. Furst et al.
NEUROBIOLOGY OF AGING (2012)
Neurotoxicity of Human Immunodeficiency Virus-1: Viral Proteins and Axonal Transport
Italo Mocchetti et al.
NEUROTOXICITY RESEARCH (2012)
The National NeuroAIDS Tissue Consortium Brain Gene Array: Two Types of HIV-Associated Neurocognitive Impairment
Benjamin B. Gelman et al.
PLOS ONE (2012)
Fingolimod, a sphingosine-1 phosphate receptor modulator, increases BDNF levels and improves symptoms of a mouse model of Rett syndrome
Ruben Deogracias et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
ION CHANNELS AND IONOTROPIC RECEPTORS IN HUMAN EMBRYONIC STEM CELL DERIVED NEURAL PROGENITORS
A. Young et al.
NEUROSCIENCE (2011)
FTY720 (fingolimod) efficacy in an animal model of multiple sclerosis requires astrocyte sphingosine 1-phosphate receptor 1 (S1P1) modulation
Ji Woong Choi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Significant Effects of Antiretroviral Therapy on Global Gene Expression in Brain Tissues of Patients with HIV-1-Associated Neurocognitive Disorders
Alejandra Borjabad et al.
PLOS PATHOGENS (2011)
The secretases: enzymes with therapeutic potential in Alzheimer disease
Bart De Strooper et al.
NATURE REVIEWS NEUROLOGY (2010)
Neurons under viral attack: Victims or warriors?
Swarupa Chakraborty et al.
NEUROCHEMISTRY INTERNATIONAL (2010)
A Placebo-Controlled Trial of Oral Fingolimod in Relapsing Multiple Sclerosis
Ludwig Kappos et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Virtual hypoxia and chronic necrosis of demyelinated axons in multiple sclerosis
Bruce D. Trapp et al.
LANCET NEUROLOGY (2009)
Phosphorylation by sphingosine kinase 2 is essential for in vivo potency of FTY720 analogues
Klemens Hoegnauer et al.
CHEMMEDCHEM (2008)
Human neural progenitor cells derived from embryonic stem cells in feeder-free cultures
Sujoy K. Dhara et al.
DIFFERENTIATION (2008)
Brain penetration of the oral immunomodulatory drug FTY720 and its phosphorylation in the central nervous system during experimental autoimmune encephalomyelitis: Consequences for mode of action in multiple sclerosis
Carolyn A. Foster et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Essential requirement for sphingosine kinase 2 in a sphingolipid apoptosis pathway activated by FTY720 analogues
Anthony S. Don et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Maturing neurons are selectively sensitive to human immunodeficiency virus type 1 exposure in differentiating human neuroepithelial progenitor cell cultures
Micheline McCarthy et al.
JOURNAL OF NEUROVIROLOGY (2006)
Sphingosine kinase type 2 is essential for lymphopenia induced by the immunomodulatory drug FTY720
B Zemann et al.
BLOOD (2006)
Immune signalling in neural development, synaptic plasticity and disease
LM Boulanger et al.
NATURE REVIEWS NEUROSCIENCE (2004)
Patterns of gene dysregulation in the frontal cortex of patients with HIV encephalitis
E Masliah et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Human immunodeficiency virus type 1 Nef protein mediates neural cell death: a neurotoxic role for IP-10
G van Marle et al.
VIROLOGY (2004)
A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease
O Carrette et al.
PROTEOMICS (2003)
Induction of pathogenic sets of genes in macrophages and neurons in neuroAIDS
ES Roberts et al.
AMERICAN JOURNAL OF PATHOLOGY (2003)
Amelioration of experimental autoimmune encephalomyelitis in lewis rats by FTY720 treatment
M Fujino et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Neuronal injury in hippocampus with human immunodeficiency virus transactivating protein, Tat
WF Maragos et al.
NEUROSCIENCE (2003)
Induction of activin A is essential for the neuroprotective action of basic fibroblast growth factor in vivo
YP Tretter et al.
NATURE MEDICINE (2000)
Share Paper
